Sajel Lala
Clinical Genetics (M.D.) · Miami, FLNPI 1023452885
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $835 and has fallen 53.1% since, to $391 in 2025.
Across 84 payments — averaging $25.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- NS Pharma, Inc.$503
- Sanofi$304
- Ultragenyx Pharmaceutical Inc.$283
- Biomarin Pharmaceutical Inc.$278
- Mirum Pharmaceuticals, Inc.$108
- Ipsen Biopharmaceuticals, Inc$100
- plus $587 from 13 others
What the payments were for
- Food & beverage$2,14899%
- Education$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| NS Pharma, Inc. | 20 | $503 |
| Sanofi | 10 | $304 |
| Ultragenyx Pharmaceutical Inc. | 7 | $283 |
| Biomarin Pharmaceutical Inc. | 12 | $278 |
| Mirum Pharmaceuticals, Inc. | 4 | $108 |
| Ipsen Biopharmaceuticals, Inc | 4 | $100 |
| AstraZeneca | 4 | $100 |
| Amicus Therapeutics, Inc. | 3 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $84 |
| Immedica Pharma US, Inc. | 2 | $45 |
| Eton Pharmaceuticals, Inc. | 2 | $44 |
| Travere Therapeutics, Inc. | 4 | $43 |
| Cycle Pharmaceuticals Inc | 2 | $34 |
| UCB, Inc. | 1 | $34 |
| PTC Therapeutics, Inc. | 1 | $31 |
| Springworks Therapeutics, Inc. | 1 | $29 |
| Acadia Pharmaceuticals Inc | 1 | $25 |
| Biogen | 1 | $19 |
| Chiesi USA, Inc. | 1 | $14 |
How this compares
$2,164 in reported general payments places this provider in the 75th percentile of 37 clinical genetics (m.d.) providers in Florida.
Other clinical genetics (m.d.) in Miami
- Parul JayakarMiami$82K
- Deborah BarbouthMiami$40K
- Irman ForghaniMiami$3K
- Ana Marie Rodriguez BarretoMiami$1K
- Thelma SugranesMiami$1K
- Paul CardenasMiami$343
- Sofia CatenaMiami$229
- Willa ThorsonMiami$71
- Mustafa TekinMiami$52
- Nicholas BorjaMiami$41
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.